Table 5: Prescription of anti-seizure medications in monotherapy
and polytherapy and their LAEP score
|
|
Drug Combinations |
Drug Combinations |
Drug Combinations |
Drug Combinations |
|
|
Monotherapy |
+ 1 ASM |
+ 2 ASM |
+
3 ASM |
+ 4 ASM |
Total |
ASM |
Levetiracetam (LEV) |
|
|
|
|
|
LAEP score |
26.7 ± 5.8 |
29.4 ± 7.4 |
28.5 ± 5.3 |
29.4 ± 6.8 |
26.9 ± 4.2 |
28.1 ± 6.2 |
N |
62 |
39 |
41 |
27 |
7 |
176 |
ASM |
Carbamazepine (CBZ) |
|
|
|
|
|
LAEP score |
27.8 ± 6.9 |
28.2 ± 6.6 |
30.3 ± 4.8 |
30.9 ± 7.2 |
27 ± 5.6 |
28.9 ± 6.3 |
N |
17 |
18 |
16 |
10 |
3 |
64 |
ASM |
Phenytoin (PHT) |
|
|
|
|
|
LAEP score |
28.7 ± 9.8 |
30.8 ± 3.8 |
29 ± 5.5 |
31.4 ±8.6 |
26 ± 5.6 |
29.6 ± 6.6 |
N |
6 |
8 |
5 |
5 |
3 |
27 |
ASM |
Sodium Valproate (SV) |
|
|
|
|
|
LAEP score |
25.8 ± 5.3 |
26.8 ± 5.6 |
29.5 ± 6.9 |
29.6 ± 6.1 |
25.6 ± 4.2 |
27.6 ± 6.02 |
N |
27 |
19 |
21 |
18 |
5 |
90 |
ASM |
Clobazam (CLB) |
|
|
|
|
|
LAEP score |
24 ± 0 |
29.1 ± 6.8 |
28.9 ± 5.7 |
28.9 ± 6.4 |
27.2 ± 4.5 |
28.9 ± 6.2 |
N |
2 |
67 |
47 |
32 |
6 |
154 |
ASM |
Lacosamide (LCM) |
|
|
|
|
|
LAEP score |
25 ± 0 |
37 ± 9.2 |
29.1
± 5.3 |
30.1 ± 6.4 |
27.7 ± 4.5 |
30.2 ±
6.4 |
N |
1 |
3 |
7 |
9 |
3 |
23 |
ASM |
Lamotrigine (LMT) |
|
|
|
|
|
LAEP score |
24 ± 0 |
33.3 ± 9.4 |
28.4 ± 7.2 |
26.8 ± 5.3 |
|
29 ±
7.5 |
N |
1 |
7 |
11 |
8 |
|
27 |
ASM |
Oxcarbamazepine (OXC) |
|
|
|
|
|
LAEP score |
29 ± 4.2 |
29.4 ± 5.5 |
26.1 ± 2.7 |
28.1 ± 5.3 |
|
27.8 ±
4.6 |
N |
2 |
11 |
13 |
9 |
|
35 |